Chemical modification of ansamitocins. II. Synthesis of 3-epimaytansionoids via 3-maytansinones

DOI: 10.1248/cpb.32.2773

Source and publish data:

Chemical and Pharmaceutical Bulletin p. 2565 - 2570 (1984)

Update date:2022-09-26

Topics:

Authors:

Akimoto Akimoto

Kawai Kawai

Hashimoto

Nomura Nomura

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1248/cpb.32.2773

Full text of DOI:10.1248/cpb.32.2773

NII-Electronic Library Service

Products guided by the article

Product name:3-epimaytansinol 3-phenylacetate

Cas No:72887-70-8

R&D Labs maybe for 72887-70-8

Chengdu Pukang Biotechnology Co., Ltd

Contact:+86-28-82550498

Address:No. 558 Rulin Road,Xinjin county,Chengdu city, China
Hangzhou LINGEBA Technology Co., Ltd.

Contact:+0086-571-87389059

Address:Office 1-913,NewYouth Plaza, GongShu Area, HangZhou,ZheJiang,P.R.China
Lyrin Industrial Corporation Limited

Contact:86-731-82571800

Address:Rm 2408,Asia Economy International Building,Shaoshan Road South,Yuhua District,Changsha,Hunan,China
Beijing Pure Chem Co.,Ltd.

Contact:+86-10-83993285

Address:Rm.1708, Haobai Tower, Building 6, No.50, North Road, West Third Ring, Haidian District, Beijing, China
Zhenjiang Haitong Chemical Industry Co., Ltd.

Contact:+86 (511) 8448-0369

Address:Baoyan Town, Dantu District, Zhenjiang City, Jiangsu, China

Relevant to this article

DABCO-mediated decarboxylative cyclization of isatoic anhydride with aroyl/heteroaroyl/alkoylacetonitriles under microwave conditions: Strategy for the synthesis of substituted 4-quinolones

Doi:10.1016/j.tetlet.2021.153187
(2021)
Site- And enantiodifferentiating C(sp³)-H oxidation enables asymmetric access to structurally and stereochemically diverse saturated cyclic ethers

Doi:10.1021/jacs.0c09636
(2020)
Doi:10.1021/jo01017a020
(1965)
ACID-CATALYSED MONOACETYLATION OF TWO 3-DEOXYHEXITOLS

Doi:10.1016/0008-6215(80)90004-X
(1980)
Development of a Strategy for Convergent Total Synthesis of the Aureolic Acid Antitumor Antibiotics

Doi:10.1021/jo00142a009
(1982)
Conformation-based restrictions and scaffold replacements in the design of hepatitis C virus polymerase inhibitors: Discovery of deleobuvir (BI 207127)

Doi:10.1021/jm4011862
(2014)

Article Doi